Represents leading research-based pharmaceutical and biotechnology companies in the US
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | THE DUBERSTEIN GROUP INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
— | |
| 2024 | THE DUBERSTEIN GROUP INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2024 | THE DUBERSTEIN GROUP INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | THE DUBERSTEIN GROUP INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | THE DUBERSTEIN GROUP INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2023 | THE DUBERSTEIN GROUP INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2023 | THE DUBERSTEIN GROUP INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2023 | THE DUBERSTEIN GROUP INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2023 | THE DUBERSTEIN GROUP INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2022 | THE DUBERSTEIN GROUP INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| THE DUBERSTEIN GROUP INC. | 59 | — |
| Issue | Activities |
|---|---|
| Health Issues | 49 |
| Medicare/Medicaid | 31 |
| Budget/Appropriations | 23 |
| Trade (domestic/foreign) | 17 |
| Pharmacy | 10 |
| Copyright/Patent/Trademark | 9 |
| Taxation/Internal Revenue Code | 8 |
| Intelligence | 1 |